One-Alpha cap    NP 

  

Manufacturer 

Leo Pharma

 

Contents

Alfacalcidol (1-α-hydroxyvit D3). 

 

MIMS Class

Agents Affecting Bone Metabolism 

 

Indications  

Diseases caused by disturbances in the Ca metabolism in consequence of reduced endogenous production of 1,25-dihydroxyvit D3. Osteoporosis. Renal osteodystrophy. Post-op or idiopathic hypoparathyroidism, pseudohypoparathyroidism. As an adjunct to the management of tertiary hyperparathyroidism. Vit D-resistant rickets or osteomalacia. Vit D-dependent rickets. Neonatal hypocalcemia or rickets. Malabsorption of Ca. Malabsorptive & nutritional rickets & osteomalacia. 

 

Dosage  

Cap Adult & childn > 20 kg body wt Initial dose: 1 mcg daily. Drops Childn < 20 kg body wt 0.05 mcg/kg/day. Neonate 0.1 mcg/kg/day. Inj Adult Initial dose: 1 mcg/dialysis. May be adjusted according to response.

 

ADMINISTRATION:

Should be taken with food. 

 

Contraindication 

Hypercalcemia. 

 

Precautions  

Infants. Lactation. 

 

Adverse Reactions  

Hypercalcemia. 

 

Drug Interaction 

Barbiturates. Anticonvulsants. 

 

Packing/Presentation   

cap

0.25mcg x 100's (RM168.85)

0.5mcg x 100's (RM272.5)

1mcg x 100's (RM397.35)

 

Pregnancy Category

Not established